These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21818511)

  • 1. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis.
    Elewski BE; Cantrell WC
    J Drugs Dermatol; 2011 Aug; 10(8):895-9. PubMed ID: 21818511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Masoudnia S; Raghifar R
    Ann Parasitol; 2013; 59(3):119-23. PubMed ID: 24881281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream.
    Goldust M; Rezaee E; Raghifar R; Hemayat S
    Ann Parasitol; 2013; 59(2):73-7. PubMed ID: 24171300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
    Draelos ZD; Feldman SR; Butners V; Alió Saenz AB
    J Drugs Dermatol; 2013 Jan; 12(1):e1-6. PubMed ID: 23377341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.
    Gold MH; Bridges T; Avakian EV; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2012 Apr; 11(4):514-8. PubMed ID: 22453590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Raghifar R
    Ann Parasitol; 2013; 59(4):173-7. PubMed ID: 24791343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Rouhani S
    Ann Parasitol; 2013; 59(1):25-9. PubMed ID: 23829055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.
    Piérard GE; Ausma J; Henry F; Vroome V; Wouters L; Borgers M; Cauwenbergh G; Piérard-Franchimont C
    Dermatology; 2007; 214(2):162-9. PubMed ID: 17341867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis.
    Sharma A; Saple DG; Surjushe A; Rao GR; Kura M; Ghosh S; Bolmall C; Baliga V
    Mycoses; 2011 May; 54(3):217-22. PubMed ID: 19925567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pityriasis versicolor be treated with 2% ketoconazole foam?
    Cantrell WC; Elewksi BE
    J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis).
    David E; Tanuos H; Sullivan T; Yan A; Kircik LH
    J Drugs Dermatol; 2013 Apr; 12(4):448-52. PubMed ID: 23652893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis.
    Savin R; Jorizzo J
    Cutis; 2006 Oct; 78(4):268-74. PubMed ID: 17121064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational evaluation of sertaconazole nitrate cream 2% in the treatment of pruritus related to tinea pedis.
    Kircik LH
    Cutis; 2009 Nov; 84(5):279-83. PubMed ID: 20099622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis.
    Borelli C; Korting HC; Bödeker RH; Neumeister C
    Cutis; 2010 Feb; 85(2):107-11. PubMed ID: 20349685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
    Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
    Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.